Abhishek Maheshwari

Congratulations on good numbers. Just a follow -up on previous participant's question. You've explained the occupancy dip in Agartala, but this blended increase that you've seen in ARPOB for Agartala and Howrah both, is it majorly because of the new high-end treatments or you took calibrated price increases across all treatments?

Okay. Good to hear. So, this is not a one-time thing. Going forward, this would be the strategy.

Okay. Secondly, can you share Raipur loss during the Q1? It was minus INR3 crores during Q4. Any update on Q1?